SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-15-069937
Filing Date
2015-02-27
Accepted
2015-02-27 16:32:22
Documents
15
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d846100d10k.htm 10-K 936823
2 EX-10.16 d846100dex1016.htm EX-10.16 118814
3 EX-21.1 d846100dex211.htm EX-21.1 3935
4 EX-23.1 d846100dex231.htm EX-23.1 4992
5 EX-31.1 d846100dex311.htm EX-31.1 8975
6 EX-31.2 d846100dex312.htm EX-31.2 8881
7 EX-32.1 d846100dex321.htm EX-32.1 3421
8 EX-32.2 d846100dex322.htm EX-32.2 3464
15 GRAPHIC g846100g76b33.jpg GRAPHIC 88632
  Complete submission text file 0001193125-15-069937.txt   8027480

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT kerx-20141231.xml EX-101.INS 975098
10 XBRL TAXONOMY EXTENSION SCHEMA kerx-20141231.xsd EX-101.SCH 62564
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kerx-20141231_cal.xml EX-101.CAL 85934
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kerx-20141231_def.xml EX-101.DEF 406018
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE kerx-20141231_lab.xml EX-101.LAB 521603
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kerx-20141231_pre.xml EX-101.PRE 481363
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30929 | Film No.: 15659587
SIC: 2834 Pharmaceutical Preparations